Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
| 0P000070H9 | CAD 54.52 0.04 0.07% |
About 62% of CI Global's investor base is looking to short. The analysis of overall sentiment of trading CI Global Health fund suggests that many investors are alarmed at this time. The current market sentiment, together with CI Global's historical and current headlines, can help investors time the market. In addition, many technical investors use CI Global Health fund news signals to limit their universe of possible portfolio assets.
0P000070H9 |
Jan 29 - Japanese drugmaker Eisai Co Ltd and U.S. biotech firm Biogen Inc said in ...
Read at kalkinemedia.com
 |
CI Global Fundamental Analysis
We analyze CI Global's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CI Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CI Global based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Ten Year Return
Ten Year Return Comparative Analysis
CI Global is currently under evaluation in ten year return among similar funds. Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
CI Global Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CI Global fund to make a market-neutral strategy. Peer analysis of CI Global could also be used in its relative valuation, which is a method of valuing CI Global by comparing valuation metrics with similar companies.
Peers
CI Global Related Equities
| HIG | Global Healthcare | 0.37 | ||||
| 0P000070I2 | CI Global | 0.17 | ||||
| 0P0001D8QF | BMO Concentrated | 0.05 | ||||
| 0P000070HA | CI Global | 0.18 |
Other Information on Investing in 0P000070H9 Fund
CI Global financial ratios help investors to determine whether 0P000070H9 Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 0P000070H9 with respect to the benefits of owning CI Global security.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |